Geriatric Clinical Trials in Mexico

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Geriatric Clinical Trials in Mexico

Geriatric Clinical Trials in Mexico – Academic CRO

Geriatric clinical trials are crucial for advancing medical knowledge and improving healthcare outcomes for older adults. In Mexico, a country with a rapidly growing aging population, the significance of geriatric research cannot be overstated. This blog post delves into the world of geriatric clinical trials in Mexico, highlighting their importance, current trends, challenges, and future prospects.

The Importance of Geriatric Clinical Trials:

Addressing the Unique Needs of Older Adults: Geriatric clinical trials focus on understanding age-related diseases, improving treatments, and enhancing the overall well-being of older adults.

By conducting research specific to this population, scientists and healthcare professionals gain valuable insights into age-related changes, multimorbidity, polypharmacy, and the efficacy of interventions for older adults.

Enhancing Quality of Care: Geriatric clinical trials pave the way for evidence-based interventions and treatment guidelines tailored to the needs of older adults. By testing novel therapies, preventive strategies, and diagnostic tools, these trials improve the quality of care and enhance the overall health outcomes for older individuals.

Current Trends in Geriatric Clinical Trials in Mexico:

Multidisciplinary Collaboration: Geriatric clinical trials in Mexico often involve collaborations between various stakeholders, including researchers, healthcare professionals, pharmaceutical companies, and government agencies.

This multidisciplinary approach ensures a comprehensive understanding of the challenges faced by older adults and facilitates the development of holistic interventions.

Focus on Age-Related Diseases: Clinical trials in Mexico predominantly target age-related diseases prevalent among the elderly, such as cardiovascular conditions, diabetes, dementia, osteoporosis, and cancer. By investigating disease progression, prevention strategies, and treatment modalities, researchers strive to improve outcomes for older adults affected by these conditions.

Inclusion of Diverse Geriatric Populations: Mexico’s geriatric clinical trials aim to encompass the diverse demographics within the older adult population, including different socioeconomic backgrounds, ethnicities, and geographical locations. This inclusivity ensures that trial outcomes are representative of the broader geriatric population and enhances the generalizability of research findings.

Challenges in Geriatric Clinical Trials in Mexico:

Recruitment and Retention: Recruiting older adults for clinical trials can be challenging due to various factors, including limited awareness, language barriers, health disparities, and logistical difficulties. Ensuring adequate representation of the geriatric population in clinical trials remains a persistent challenge that requires innovative recruitment strategies and community engagement.

Polypharmacy and Comorbidities: Older adults often have multiple chronic conditions and take multiple medications simultaneously, leading to complex interactions and potential safety concerns. Geriatric clinical trials must carefully consider these factors to ensure participant safety and to assess the effectiveness of interventions within the context of real-world scenarios.

Ethical Considerations: Geriatric clinical trials must adhere to stringent ethical guidelines to protect the rights and well-being of older participants. This includes informed consent procedures, ensuring the inclusion of vulnerable populations, and prioritizing participant safety throughout the trial.

Geriatric Clinical Trials in Mexico

Geriatric Clinical Trials in Mexico

Geriatric Clinical Trials in Mexico

Future Prospects and Initiatives:

Longitudinal Studies: Long-term follow-up studies are vital to understanding the efficacy and long-term impact of interventions on older adults. By conducting longitudinal studies, researchers in Mexico can gather valuable data on the progression of age-related diseases and the effectiveness of interventions over an extended period.

Personalized Medicine: Advancements in genetics and precision medicine offer opportunities for tailoring interventions to individual geriatric patients. Clinical trials exploring personalized medicine approaches can provide valuable insights into optimizing treatment strategies, minimizing adverse events, and enhancing therapeutic outcomes.

Collaborative International Research: Engaging in collaborative research initiatives with international partners allows Mexican researchers to access a broader range of expertise, resources, and diverse populations.

Such collaborations can foster the exchange of knowledge, methodologies, and innovative approaches in geriatric clinical trials. They also enable researchers to conduct large-scale studies with increased statistical power and generalizability.

Technology and Digital Health: Leveraging technological advancements and digital health solutions can revolutionize geriatric clinical trials in Mexico.

Remote monitoring, telemedicine, wearable devices, and mobile applications can facilitate data collection, improve participant engagement, and enhance the overall efficiency of clinical trials, particularly for older adults who may face mobility or transportation challenges.

Geriatric Education and Training: Investing in geriatric education and training programs for healthcare professionals and researchers is crucial to build a skilled workforce capable of conducting high-quality geriatric clinical trials. By equipping professionals with specialized knowledge and skills in geriatrics, Mexico can enhance its capacity to address the unique healthcare needs of older adults.


Geriatric clinical trials play a pivotal role in advancing healthcare for the aging population in Mexico. By focusing on age-related diseases, collaborating across disciplines, and addressing unique challenges, researchers in Mexico are contributing to the development of evidence-based interventions and treatment guidelines specifically tailored to older adults.

Despite the challenges of recruitment, polypharmacy, and ethical considerations, the future of geriatric clinical trials in Mexico holds promise. Longitudinal studies, personalized medicine approaches, international collaborations, and the integration of technology are key areas of focus that will drive innovation and improve the quality of care for older adults.

By prioritizing geriatric research, Mexico can continue to make significant strides in promoting healthy aging and enhancing the well-being of its aging population.

Geriatric Clinical Trials in Mexico

Source: Roche

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Geriatric Clinical Trials in Mexico

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Geriatric Clinical Trials in Mexico

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Geriatric Clinical Trials in Mexico

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Geriatric Clinical Trials in Mexico

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Geriatric Clinical Trials in Mexico

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Geriatric Clinical Trials in Mexico

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Geriatric Clinical Trials in Mexico

The Cohortias Team

Geriatric Clinical Trials in Mexico

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Geriatric Clinical Trials in Mexico

Network & Partnerships